In the late 'sixties and early 'seventies the need for standardisation of the immunofluorescence technique (IFT) was expressed at several international meetings. 13 
content of the serum further by indicating the intensity of the fluorescence-that is, weak, moderate, or strong. This is of course less time consuming than the study of a proper dilution series. In view of the considerable number of tests requested this is a factor of importance.6 The fact that international journals accept articles in which the measurement of ANAs is given in titres instead of IUs has also hampered the introduction of the use of reference preparations.
It is well known that high titres (>1/1000) are found particularly in systemic lupus erythematosus (SLE) 
Materials and methods

REFERENCE SERUM
Plasma was obtained during therapeutic plasmapheresis from two patients with SLE. Clotting was promoted by the addition of thrombin. The sera were mixed so that the distribution of IgG and IgM class ANA of the homogeneous type resembled the ratio in the WHO preparation. Ampoules containing 1 ml were freeze dried and sealed.
STABILITY TESTING
Four hundred and eighty ampoules with the freeze dried Dutch reference serum preparation were stored in groups of 24 for one month, three months, six months, nine months, and one year at four temperatures-namely, -196°C, -20°C, 4°C, and room temperature. After storage for one year at room temperature no reduction of the ANA titre was detected. Storage at 37°C for only three months, however, diminished the solubility of the freeze dried powder. One hundred and twenty ampoules were opened, reconstituted with 1 ml distilled water, and stored for one week, two weeks, one month, three months, and six months at -20°C. The results showed no reduction in titre. CALIBRATION In a first test five laboratories of the Dutch working group measured the ANA level in five test sera and a common reference preparation on three different days. All participants used the same conjugate preparations but were free to choose substrate (rat liver, baby hamster kidney cells, human granulocytes). Simultaneously fibroblasts from the same culture were used as substrate by all participants. Table 2 summarises the results of the statistical analysis. It appeared that when different substrates were used the value of F in the analysis of variance increased after standardisation, showing the expression in IU had no favourable effect. Calculating the F values for rat liver only yielded the same result, but with fibroblasts the decrease of F was significant after omitting one apparent outlier. read. An effect of only borderline significance was achieved by standardisation (Table 3) with F' having a p value between 0-05 and 0-1. Table 4 shows the results analysed according to substrate. It is seen that a significant effect of standardisation was obtained only with HEp2 cells. On average the total range of readings was reduced by half after standardisation. Fig. 1 gives an example of the effect of standardisation on the results obtained with one serum. Although with fibroblasts the F values decreased after standardisation, this
TEST WITH A I ARGE GROUP OF P A R T I C I P A N T S
In this test 26 laboratories agreed to perform on one day IFT titrations on five serum samples from patients with SLE and normal subjects, and the reference serum, using their own substrate and conjugate. The resulting titres were converted into JUs assuming the Dutch reference serum to contain 200 IU/ml. Results using all substrates were accepted, and the 26 laboratories produced 34 result files that could be analysed. Rat liver was used in 17 cases as substrate, HEp2 cells in 11 cases, and fibroblasts in four cases. One laboratory used human granulocytes and another mouse kidney. 
was not significant (F'<1). Again with rat liver the use of a reference preparation did not decrease interlaboratory spread.
Discussion
ANA determination is often used as a screening method for further serological studies, including the LE cell and tests for antibodies to DNA or to extractable nuclear antigens. In such studies a positive result at a particular serum dilution may give sufficient information. If, however, the ANA determination itself is to be used to suggest further clinical investigation for generalised autoimmune diseases, quantification can be of use.8 The same applies to longitudinal observations of individual patients; also for the interpretation of scientific studies-for example, comparisons of serological tests in the field of generalised autoimmune diseases or of 'lumping' or 'splitting' in disease classificationquantitative results of ANA determinations are needed. A wide variation in titres between laboratories is evident, especially when different substrates and types of microscopes are used. Nakamura and Rippey recently showed that one serum tested by a number of laboratories had titres between 1/8 and 1/640.12 For interlaboratory comparison the expression of the results in IUs should therefore be promoted for the same reasons that have been discussed earlier for rheumatoid factor measurements.14 The present study has shown that this can be achieved also for homogeneous ANA determinations.
From our experiments it appears that rat liver is unsuitable as a substrate for ANA measurement if interlaboratory comparability is required, and cultured cells are to be preferred. The HEp2 cells gave better results than fibroblasts in interlaboratory comparison.
Thus if the appropriate substrates have been used a reference serum permits the expression of quantitative ANA measurements in IU. The experiments with rat liver, as indicated in Tables 2 and 4 , did not suggest that standardisation of conjugates10 might give a further improvement in comparability. Use of one batch of rat liver seemed to have a slightly favourable effect (Tables 3 and 4) .
A value of 200 IU has been assigned to the Netherlands reference serum, based on comparison with the WHO reference preparation 66/233 using rat liver as a substrate. We propose this value be used also for other substrates. Whether this will always remain valid for particular substrates or methods of cell culture may be a subject for future studies.
A further problem is that whereas the IFT allows 
